Synaptogenix Announces Live Appearance of its President and CSO on Streaming Financial News Network

NEW YORK, Aug. 12, 2022 /PRNewswire/ -- Synaptogenix, Inc. (Nasdaq: SNPX) ("the Company"), a clinical-stage biopharmaceutical company developing regenerative therapeutics for neurodegenerative disorders, today announced that Dr. Daniel L. Alkon , the Company's President and Chief Scientific Officer, will appear as a featured guest on TD Ameritrade Network's "Trading 360" today, Friday, August 12, 2022 at 10:30am Eastern time (www.TDameritradenetwork.com).

Read more at prnewswire.com